
-
Swiatek cruises, Osaka battles through in Montreal
-
Meta beats expectations sending share price soaring
-
Gaza civil defence says 30 killed in food queue by Israeli fire
-
Microsoft quarterly profits soar on AI and cloud growth
-
Airbus first-half profit climbs 85% to $1.7 bn
-
TikTok launches crowd-sourced debunking tool in US
-
'Ours forever': would-be Israeli settlers march on Gaza
-
Trump punishes Brazil with tariffs, sanctions over trial of ally Bolsonaro
-
US sprinter Kerley out of US trials
-
Ukraine will fix anti-graft law, minister tells AFP ahead of crucial vote
-
Tata Motors to buy Italy's Iveco for $4.4 bn
-
From skies over Gaza, Jordanian crew drops lifeline to civilians
-
US Fed holds firm against Trump pressure as divisions emerge
-
Michael Jackson's dirty sock sells for over $8,000 in France
-
Turkish city calls for help after heat tops 50C
-
Renault names Provost CEO after De Meo exit
-
Le Court makes history for Africa at women's Tour de France
-
Canada central bank holds rate steady citing US tariff 'threats'
-
Henry puts New Zealand in control of 1st Test against Zimbabwe
-
Stocks edge higher, dollar gains before tech earnings, Fed decision
-
Palestine Action wins bid to challenge terror ban in London court
-
EU urged to act on forests' faltering absorption of carbon
-
India secures return of ancient Buddhist gems
-
Stokes braced for 'emotional' tribute to late England batsman Thorpe
-
France's Luc Besson resurrects new 'romantic' Dracula
-
Trump hits India with 25% tariff and 'penalty' over Russia ties
-
Chinese sub discovers deepest-ever creatures 10 km undersea
-
Kingscote revels in being the 'villain' of Sussex Stakes shock
-
English cricket chiefs confirm sale of six Hundred franchises
-
Wirtz opens Liverpool account in friendly win in Japan
-
Marchand shatters record as US, Australia win more world gold
-
Thousands honour Ozzy Osbourne at UK hometown funeral procession
-
WHO chief says continuous medical aid into Gaza 'critical'
-
London court rules oligarch liable in $1.9 bn Ukraine loan scheme
-
England's Stokes out of India series decider with shoulder injury
-
Stocks diverge, dollar gains before tech earnings, Fed decision
-
India's Gill says Oval groundsman caused 'unnecessary' row
-
Physicists still divided about quantum world, 100 years on
-
Russia relieved as tsunami spares far east from major damage
-
'Can't believe it': Marchand shatters long-standing world record
-
French govt prepares new law to return colonial-era art
-
London court rules oligarch liable over $1.9 bn Ukraine loan scheme
-
Olympic biathlon champion confirmed dead after Pakistan mountaineering accident
-
German biathlete confirmed dead after accident on Pakistan mountain
-
Marchand smashes long-standing 200m medley world record
-
US economy returns to growth in second quarter on tariff turbulence
-
'All gone': Beijing villagers left with nothing after deadly floods
-
Aston Martin pares outlook as US tariffs weigh
-
Adidas says may hike US prices after tariff cost warning
-
GSK reports improved outlook despite US drug tariffs
RBGPF | -4.75% | 74.03 | $ | |
RYCEF | -2.14% | 13.1 | $ | |
CMSC | -0.04% | 22.6 | $ | |
NGG | -0.47% | 70.19 | $ | |
AZN | 3.41% | 76.59 | $ | |
GSK | 3.34% | 38.97 | $ | |
VOD | -0.45% | 11.06 | $ | |
BTI | 0.73% | 53.16 | $ | |
RIO | -4.67% | 59.49 | $ | |
RELX | -0.27% | 51.78 | $ | |
SCU | 0% | 12.72 | $ | |
BCC | -1.47% | 84.89 | $ | |
SCS | -1.74% | 10.33 | $ | |
BP | -2.2% | 32.25 | $ | |
JRI | 0.38% | 13.11 | $ | |
CMSD | -0.26% | 23.06 | $ | |
BCE | -0.55% | 23.53 | $ |

US cutting Gavi vaccine alliance aid may cause 'over a million deaths'
The United States cutting funding to Gavi, an organisation that provides vaccines to the world's poorest countries, could result in more than a million deaths and will endanger lives everywhere, the group's CEO warned on Thursday.
The news that Washington is planning to end funding for Gavi, first reported in the New York Times, comes as the two-month-old administration of President Donald Trump aggressively slashes foreign aid.
The decision was included in a 281-page spreadsheet that the severely downsized United States Agency for International Development sent to Congress on Monday night.
Gavi's chief executive Sania Nishtar told AFP the alliance had "not received a termination notice from the US government".
The alliance was "engaging with the White House and Congress with a view to securing $300 million approved by Congress for our 2025 activities and longer-term funding", Nishtar said.
"A cut in Gavi's funding from the US would have a disastrous impact on global health security, potentially resulting in over a million deaths from preventable diseases and endangering lives everywhere from dangerous disease outbreaks," she said.
Health experts and organisations have warned that cutting Gavi's funding would ultimately cost the world more money and set back a quarter-century of progress in the fight against many deadly diseases.
Jennifer Nuzzo, a professor of epidemiology at Brown University in the United States, said the "mind-bogglingly short-sighted proposal" would have "devastating consequences for the health of children everywhere".
"US support for Gavi's vaccination efforts is not charity -- it's a cost-effective investment to prevent deadly and costly outbreaks that can come here," she told AFP.
- 'Cruel' -
Gavi says it helps vaccinate more than half the world's children against infectious diseases including Covid-19, Ebola, malaria, rabies, polio, cholera, tuberculosis (TB), typhoid and yellow fever.
The United States currently provides around a quarter of the budget of Gavi, a public-private partnership headquartered in Geneva.
David Elliman, a child health researcher at University College London, said cutting funding "is not only cruel, but is not in the interests of anyone".
"If diseases such as measles and TB increase anywhere in the world, it is a hazard to us all," he told the Science Media Centre, adding that measles was already rising in the United States, Europe and elsewhere.
In the face of the Trump administration's sweeping aid cuts, "institutions are reluctant to speak out in case they are targeted and individuals are self-censoring to protect themselves," said Andrew Pollard, head of the Oxford Vaccine Group.
"We must wake up to the moral case for supporting the remarkable global health efforts that help the poor of the world, but also remember that it is in our own interest," he added.
"As the Covid-19 pandemic reminds us, infectious diseases cross borders and put all of us at risk."
- 'We will regret this' -
Several health researchers also said the cuts would be a poor return on investment.
For every $1 spent on vaccinations in developing countries where Gavi operates, $21 will be saved this decade in "health care costs, lost wages and lost productivity from illness and death", the vaccine group estimates.
A report from the Johns Hopkins Bloomberg School of Public Health recently found that costs averted by vaccine programmes in 73 countries will add up to nearly $782 billion over the next decade.
Craig Spencer, a doctor and Ebola survivor at Brown University, said the loss of US support to Gavi means "kids will die".
He also warned that Gavi maintains the global stockpile of vaccines for diseases including Ebola, cholera, yellow fever and more.
"We will regret this," Spencer wrote on X.
T.Zimmermann--VB